Article
Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition
27 Feb 2014
Abstract excerpt
INTRODUCTION: Tau pathology is associated with a number of age-related neurodegenerative disorders. Few treatments have been demonstrated to diminish the impact of tau pathology in mouse models and none are yet effective in humans. Histone deacetylase 6 (HDAC6) is an enzyme that removes acetyl groups from cytoplasmic proteins, rather than nuclear histones. Its substrates include tubulin, heat shock protein 90 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
